Facial recognition AI measures success of browlifts

Machine learning can deliver an objective appraisal of cosmetic surgery’s success at making aging faces appear younger and happier, according to Mayo Clinic researchers.

Plastic surgeon Thanapoom Boonipat, MD, and colleagues used commercially available expression-recognition software to gauge the apparent emotions of 52 patients who’d undergone browlifts.

This popular procedure is typically sought out by individuals concerned about eyebrows lowering over time, which can cause the face at rest to appear downcast, brooding or irked.

Before the procedures, the software labeled 13.06% of patients’ resting faces as angry.

After, the figure dropped to 5.42%.

Meanwhile happy readings bounced from 1.68% to 9.35% and sad fell from 13.06% to 5.42%.

In their study report, published Sept. 27 in Aesthetic Plastic Surgery, Boonipat and co-authors note the subjectivity of traditional means of assessing cosmetic or corrective facial procedures of all kinds.

Most facelift outcomes are “based on instinctive analysis of the aesthetic surgeon rather than on patient assessments, public opinions or other objective means,” they comment. “We employed an artificial intelligence system to objectively measure the impact of browlifts and associated rejuvenation procedures on the appearance of emotion while the patient is in repose.”

The present study, they conclude, “proposes a paradigm shift in the clinical evaluation of browlift and other facial aesthetic surgery, implementing an existing facial emotion recognition system to quantify changes in expression associated with facial surgery.”

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.